Subcellular Localization of uc.8+ as a Prognostic Biomarker in Bladder Cancer Tissue.

bladder cancer long noncoding RNA prognostic biomarker transcribed-ultraconserved region ultraconserved region

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
08 Feb 2021
Historique:
received: 12 12 2020
revised: 29 01 2021
accepted: 03 02 2021
entrez: 11 2 2021
pubmed: 12 2 2021
medline: 12 2 2021
Statut: epublish

Résumé

Non-coding RNA transcripts originating from Ultraconserved Regions (UCRs) have tissue-specific expression and play relevant roles in the pathophysiology of multiple cancer types. Among them, we recently identified and characterized the ultra-conserved-transcript-8+ (uc.8+), whose levels correlate with grading and staging of bladder cancer. Here, to validate uc.8+ as a potential biomarker in bladder cancer, we assessed its expression and subcellular localization by using tissue microarray on 73 human bladder cancer specimens. We quantified uc.8+ by in-situ hybridization and correlated its expression levels with clinical characteristics and patient survival. The analysis of subcellular localization indicated the simultaneous presence of uc.8+ in the cytoplasm and nucleus of cells from the Low-Grade group, whereas a prevalent cytoplasmic localization was observed in samples from the High-Grade group, supporting the hypothesis of uc.8+ nuclear-to-cytoplasmic translocation in most malignant tumor forms. Moreover, analysis of uc.8+ expression and subcellular localization in tumor-surrounding stroma revealed a marked down-regulation of uc.8+ levels compared to the paired (adjacent) tumor region. Finally, deep machine-learning approaches identified nucleotide sequences associated with uc.8+ localization in nucleus and/or cytoplasm, allowing to predict possible RNA binding proteins associated with uc.8+, recognizing also sequences involved in mRNA cytoplasm-translocation. Our model suggests uc.8+ subcellular localization as a potential prognostic biomarker for bladder cancer.

Identifiants

pubmed: 33567603
pii: cancers13040681
doi: 10.3390/cancers13040681
pmc: PMC7914980
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Horizon 2020 Framework Programme
ID : 801338.
Organisme : My First AIRC Grant
ID : 23453
Organisme : SATIN-POR CAMPANIA
ID : FESR 2014/2020

Références

PLoS Comput Biol. 2019 Mar 5;15(3):e1006701
pubmed: 30835723
RNA. 2009 Oct;15(10):1896-908
pubmed: 19656867
Mol Cell Biol. 1994 Nov;14(11):7219-25
pubmed: 7523861
Genetica. 1994;94(2-3):101-14
pubmed: 7896132
Cancer Cell. 2007 Sep;12(3):215-29
pubmed: 17785203
Science. 2007 Aug 17;317(5840):915
pubmed: 17702936
Science. 2004 May 28;304(5675):1321-5
pubmed: 15131266
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Mol Cell Biol. 1993 May;13(5):2993-3001
pubmed: 8474457
EMBO J. 1999 Aug 2;18(15):4332-47
pubmed: 10428971
N Engl J Med. 2016 Sep 22;375(12):1109-12
pubmed: 27653561
Cell. 2013 Jul 3;154(1):26-46
pubmed: 23827673
Algorithms Mol Biol. 2011 Nov 24;6:26
pubmed: 22115189
Cell Rep. 2015 Aug 18;12(7):1089-98
pubmed: 26257179
Oncotarget. 2016 Apr 12;7(15):20636-54
pubmed: 26943042
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Transl Res. 2017 Jun;184:108-117
pubmed: 28438520
Genes (Basel). 2016 Dec 14;7(12):
pubmed: 27983635
J Biol Chem. 1986 Aug 25;261(24):11266-73
pubmed: 3733753
Heliyon. 2019 Nov 14;5(11):e02785
pubmed: 31844718
PLoS Genet. 2014 Oct 23;10(10):e1004646
pubmed: 25340765
Biotechniques. 2007 Jul;43(1 Suppl):31, 33-6
pubmed: 17936940
Int J Urol. 2017 Oct;24(10):730-734
pubmed: 28543959
Sci Rep. 2018 Nov 6;8(1):16385
pubmed: 30401954
Expert Rev Mol Diagn. 2018 Apr;18(4):347-356
pubmed: 29542328
Mol Cell Biol. 2000 Dec;20(23):8996-9008
pubmed: 11073998
Genome Biol. 2015 Jan 29;16:20
pubmed: 25630241
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Virology. 1999 Sep 15;262(1):200-9
pubmed: 10489353
Proc Natl Acad Sci U S A. 2012 May 8;109(19):E1183-91
pubmed: 22496592
Database (Oxford). 2016 Apr 07;2016:
pubmed: 27055826
Trends Biochem Sci. 2016 Sep;41(9):761-772
pubmed: 27499234
Wiley Interdiscip Rev RNA. 2020 Mar;11(2):e1567
pubmed: 31489780
Nat Methods. 2015 Feb;12(2):115-21
pubmed: 25633503
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W451-4
pubmed: 16845047
J Cell Biol. 2019 Sep 2;218(9):2962-2981
pubmed: 31375530
Eur Urol. 2017 Mar;71(3):462-475
pubmed: 27375033

Auteurs

Sara Terreri (S)

Institute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council (CNR), 80131 Naples, Italy.
Immunology Research Area, B-cell development Unit, Children Hospital Bambino Gesù, 00146 Rome, Italy.

Sara Mancinelli (S)

Institute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council (CNR), 80131 Naples, Italy.
Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan, Italy.
IRCCS Humanitas Research Hospital, 20089 Rozzano, Milan, Italy.

Matteo Ferro (M)

Division of Urology, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Maria Concetta Vitale (MC)

Department of Science and Technology, University of Naples Parthenope, 80143 Naples, Italy.

Sisto Perdonà (S)

Uro-Gynecological Department, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale"-IRCCS, 80131 Naples, Italy.

Luigi Castaldo (L)

Uro-Gynecological Department, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale"-IRCCS, 80131 Naples, Italy.

Vincenzo Gigantino (V)

Pathology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale"-IRCCS, 80131 Naples, Italy.

Vincenzo Mercadante (V)

Institute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council (CNR), 80131 Naples, Italy.

Rossella De Cecio (R)

Pathology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale"-IRCCS, 80131 Naples, Italy.

Gabriella Aquino (G)

Pathology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale"-IRCCS, 80131 Naples, Italy.

Marco Montella (M)

Section of Pathology, Department of Physical and Mental Health and Preventive Medicine, Università degli studi della Campania "Luigi Vanvitelli", 80131 Naples, Italy.

Claudia Angelini (C)

Institute for Applied Mathematics "Mauro Picone", National Research Council (CNR), 80131 Naples, Italy.

Eugenio Del Prete (E)

Institute for Applied Mathematics "Mauro Picone", National Research Council (CNR), 80131 Naples, Italy.

Marianna Aprile (M)

Institute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council (CNR), 80131 Naples, Italy.

Angelo Ciaramella (A)

Department of Science and Technology, University of Naples Parthenope, 80143 Naples, Italy.

Giovanna L Liguori (GL)

Institute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council (CNR), 80131 Naples, Italy.

Valerio Costa (V)

Institute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council (CNR), 80131 Naples, Italy.

George A Calin (GA)

Translational Molecular Pathology Department and Leukemia Department, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Evelina La Civita (E)

Department of Translational Medical Sciences, University of Naples "Federico II", 80131 Naples, Italy.

Daniela Terracciano (D)

Department of Translational Medical Sciences, University of Naples "Federico II", 80131 Naples, Italy.

Ferdinando Febbraio (F)

Institute of Biochemistry and Cell Biology, National Research Council (CNR), 80131 Naples, Italy.

Amelia Cimmino (A)

Institute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council (CNR), 80131 Naples, Italy.

Classifications MeSH